PALISADE Follow-on Study (ARC004)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Peanut Allergy
Related studies linked through entity extraction aliases.
HAL-MPE1 Safety and Tolerability Study
- Status
- COMPLETED
- Phase
- PHASE1
Clinical and Biological Efficacy of Peanut Oral Immunotherapy
- Status
- COMPLETED
- Phase
- N/A
Visual Recognition of Allergens by Allergic Patients and/or Their Parents
- Status
- COMPLETED
- Phase
- N/A
Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Viaskin Peanut to Treat Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Identification of Anaphylactogenic Antibodies in Peanut Allergy
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
High Threshold Peanut Challenge Study
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE3
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
FARE Peanut SLIT and Early Tolerance Induction
- Status
- COMPLETED
- Phase
- PHASE2
Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study
- Status
- COMPLETED
- Phase
- PHASE2
Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy
- Status
- COMPLETED
- Phase
- N/A
HAL-MPE1 First-in-human
- Status
- COMPLETED
- Phase
- PHASE1
The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery
- Status
- COMPLETED
- Phase
- PHASE2
Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT
- Status
- COMPLETED
- Phase
- PHASE2